Kenichi Ogawa Given A One-Year Suspension By Japanese Boxing Commission For Positive Drug Test

The fallout of Kenichi Ogawa's positive drug test last year continues to bring more problems for Ogawa.

After Ogawa was stripped of the IBF super featherweight title and given a six-month drug suspension by the Nevada State Athletic Commission for testing positive for androstanediol, the Japanese Commission has suspended Ogawa for a year, according to Boxing Scene. 

Ogawa originally defeated Tevin Farmer in Las Vegas on the December 9, 2017 HBO boxing telecast. The fight ended with Ogawa picking up the vacant IBF title that was stripped from Gervonta Davis with a controversial split decision win. Soon after, news of his positive urine test, which took place on December 5, went public which meant the title was going to be vacant once more and the fight was changed from an Ogawa victory to a no contest. Ogawa was also fined $14,000, 20 percent of his $70,000 purse from his fight against Farmer.

The suspension is retroactive to December 10, 2017 and will end on December 10, 2018. The suspension came as the commission believed Ogawa's positive test hurts the sport's credibility in Japan while the country has had an increase in the number of fighters missing weight there in the past 12 months. According to Asian Boxing, it is believed to be the first time ever the JBC has suspended a Japanese boxer for a positive drug test.

Since then, the IBF has ordered Farmer and Billy Dib, the organization's two-highest ranked available fighters, to compete for the vacant title.